New hope for rare bleeding disorder: Long-Term drug shows promise
NCT ID NCT03879135
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a drug called rVWF (Vonvendi) in 38 children and adults with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular use of the drug could reduce the number of spontaneous bleeding episodes over a year. Participants received treatment for up to three years, and researchers tracked safety and bleeding rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Recombinant von Willebrand factor (rVWF, also called Vonvendi or Vonicog alfa)
- What this could lead to
- If successful, this could provide a long-term treatment option to prevent spontaneous bleeding episodes in people with severe von Willebrand disease.
- What could go wrong
- This is a small, open-label study with no control group, so results may not apply to all patients. Side effects or lack of effectiveness in some individuals remain possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE VON WILLEBRAND DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AKH - Medizinische Universität Wien
Vienna, Austria
-
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas, 72202, United States
-
Azienda Ospedaliera Pediatrica Santobono Pausillipon
Naples, Italy
-
Azienda Ospedaliera Universitaria Careggi
Florence, 50134, Italy
-
Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza
Roma, 00185, Italy
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Ege University Medical Faculty
Izmir, 35040, Turkey (Türkiye)
-
Ege University Medical Faculty
Izmir, 35100, Turkey (Türkiye)
-
Erasmus Medisch Centrum
Rotterdam, 3015 AA, Netherlands
-
Erasmus Medisch Centrum
Rotterdam, 3015 CN, Netherlands
-
FSBI of Science "Kirov Scientific and Research Institute of Hematology and Blood Transfusion of FMBA
Kirov, 610017, Russia
-
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
Milan, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
-
Groupe Hospitalier Pellegrin - Hôpital Pellegrin
Gironde, France
-
Groupement Hospitalier Est- Hôpital Louis Pradel
Bron, 69677, France
-
Groupement Hospitalier Sud - Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
-
Hopital Cardiologique - CHU Lille
Lille, Nord, France
-
Hospital General Universitario de Alicante
Alicante, 03010, Spain
-
Hospital Universitari i Politecnic La Fe
Valencia, 46026, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hôpital Necker - Enfants Malades
Paris, Paris, 75015, France
-
Indiana Hemophilia and Thrombosis Center
Indianapolis, Indiana, 46260, United States
-
Istanbul University Oncology Institute
Istanbul, Turkey (Türkiye)
-
Klinikum der Johann Wolfgang Goethe-Universitaet
Frankfurt, Germany
-
Medical University of South Carolina (MUSC)
Charleston, South Carolina, 29425, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
Ondokuz Mayis Univ. Med. Fac.
Samsun, 55139, Turkey (Türkiye)
-
Ospedale Pediatrico Bambino Gesù
Roma, Italy
-
Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106, United States
-
SAIH "Kemerovo Regional Clinical Hospital"
Kemerovo, 650066, Russia
-
University of Colorado Health
Aurora, Colorado, 80045, United States
-
University of Florida College of Medicine
Gainesville, Florida, 32610, United States
-
Werlhof-Institut GmbH
Hanover, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New shot aims to tame bleeding disorder in small trial
- New algorithm aims to stop dangerous bleeding in VWD patients
- New hope for kids with rare bleeding disease: study tests rVWF therapy
- Family history questions may improve bleeding disorder detection in kids
- New drug aims to lighten heavy periods for bleeding disorder patients
- UK doctors look back at real-world use of new VWD drug